1. Home
  2. AORT vs HROW Comparison

AORT vs HROW Comparison

Compare AORT & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$35.22

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$33.90

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AORT
HROW
Founded
1984
1998
Country
United States
United States
Employees
1800
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
AORT
HROW
Price
$35.22
$33.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
8
Target Price
$48.76
$71.14
AVG Volume (30 Days)
320.7K
992.4K
Earning Date
05-04-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
165.62
N/A
EPS
0.21
N/A
Revenue
$298,836,000.00
N/A
Revenue This Year
$14.20
$32.90
Revenue Next Year
$11.17
$48.52
P/E Ratio
$173.14
N/A
Revenue Growth
18.01
N/A
52 Week Low
$21.97
$20.85
52 Week High
$48.25
$54.98

Technical Indicators

Market Signals
Indicator
AORT
HROW
Relative Strength Index (RSI) 36.98 34.70
Support Level $34.60 $32.55
Resistance Level $38.42 $41.49
Average True Range (ATR) 1.11 1.54
MACD 0.05 0.21
Stochastic Oscillator 10.32 19.45

Price Performance

Historical Comparison
AORT
HROW

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: